- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
New Medicines in the U.S. Biopharmaceutical Pipeline Webinar Jan. 17, 2013, Part III
John Lechleiter, PhD, Chairman, President, and Chief Executive Officer of Eli Lilly and Company and the Chairman of PhRMA joins PhRMA President and CEO John Castellani and Genia Long, Managing Principal, Analysis Group for this Webinar to discuss the future of biopharmaceutical innovation.
